| Literature DB >> 35630592 |
Bayirta V Egorova1, Lyubov S Zamurueva1, Anastasia D Zubenko2, Anna V Pashanova2,3, Artem A Mitrofanov1, Anna B Priselkova4, Yuri V Fedorov2, Alexander L Trigub5, Olga A Fedorova2, Stepan N Kalmykov1.
Abstract
A synthetic procedure for the synthesis of azacrown ethers with a combination of pendant arms has been developed and the synthesized ligand, characterized by various techniques, was studied. The prepared benzoazacrown ether with hybrid pendant arms and its complexes with copper and lead cations were studied in terms of biomedical applications. Similarly to a fully acetate analog, the new one binds both cations with close stability constants, despite the decrease in both constants. The calculated geometry of the complexes correlate with the data from X-ray absorption and NMR spectroscopy. Coordination of both cations differs due to the difference between the ionic radii. However, these chelation modes provide effective shielding of cations in both cases, that was shown by the stability of their complexes in the biologically relevant media towards transchelation and transmetallation.Entities:
Keywords: azacrown ether; copper-64; lead-212; list three to ten; radiopharmaceutical; stability of complexes
Mesh:
Substances:
Year: 2022 PMID: 35630592 PMCID: PMC9143346 DOI: 10.3390/molecules27103115
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.927
Figure 1Ligands H3BA3A and H2BA2A1Py.
Scheme 1Reagents and conditions: (a) 2-(chloromethyl)pyridine hydrochloride, K2CO3, MeCN, reflux; (b) (1) BH3 THF, 0 °C, Ar, (2) HCl, H2O, reflux, (3) KOH, H2O, 0 °C, Ar; (c) tert-butyl bromoacetate, K2CO3, KI, MeCN, reflux; (d) H2O, reflux.
Protonation constants of BA2A1Py2− and the closest analog BA3A3− and stability constants of the studied complexes.
| Cation | Complex | BA2A1Py2− | BA3A3− [ | |
|---|---|---|---|---|
| 0.1 M NaClO4 | 0.1 M KNO3 | 0.1 M KNO3 | ||
| H+ | HL | 9.0 (1) | 9.3 (1)/9.3 | 9.9 (1)/9.9 |
| H2L | 16.7 (1) | 17.0 (1)/7.7 | 17.7 (1)/7.8 | |
| H3L | 21.2 (1) | 20.8 (1)/3.8 | 21.2 (1)/3.5 | |
| H4L | 22.9 (1) | 22.5 (1)/1.7 | 23.8 (2)/2.6 | |
| Cu2+ | HLCu | 21.2 (1) | 20.0 (1) | 20.4 (1) |
| LCu | 16.2 (2) | 16.3 (1) | 16.8 (1) | |
| LCuOH | 18.8 (2) | 18.6 (1) | ||
| Pb2+ | HLPb | - | 18.6 (1) | 20.1 ± 0.1 |
| LPb | - | 15.6 (1) | 17.2 ± 0.1 | |
| LPbOH | - | 20.2 (2) | 23.1 ± 0.1 | |
| LPb(OH)2 | - | 22.4 (2) | 26.3 ± 0.1 | |
charges are omitted for clarity.
Figure 2pH distribution diagrams for BA2A1Py.
Figure 31H NMR spectra of ligand H and its complex with Pb2+ at various pD values in D2O.
Figure 4pH distribution diagrams for complexes of Cu2+ (a) and Pb2+ (b) with BA2A1Py.
Figure 5Optimized geometries of complexes of BA2A1Py with Cu2+ (a) and Pb2+ (b).
Structural parameters refined from fitting the EXAFS Cu K- and Pb L3- edges spectra for CuBA2A1Py and PbBA2A1Py complexes solutions at varied pHs.
| Sample | N/O | C/N/O | C/N/O | C/N/O | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| N | R, Å | σ, Å | N | R, Å | σ, Å | N | R, Å | σ, Å | N | R, Å | σ, Å | |
| Cu | 4.0 | 2.00 | 0.011 | 4.6 | 2.72 | 0.005 | 6.9 | 2.94 | 0.005 | 1.6 | 3.29 | 0.005 |
| Cu | 4.0 | 1.99 | 0.010 | 3.4 | 2.73 | 0.005 | 5.7 | 2.92 | 0.005 | 2.2 | 3.41 | 0.005 |
| Pb | 5.5 | 2.54 | 0.014 | 6.6 | 3.31 | 0.009 | - | |||||
| Pb | 6.1 | 2.55 | 0.016 | 8.6 | 3.31 | 0.009 | ||||||
Figure 6The fitted spectra for X-ray absorption of copper (a) and lead (b) complexes with H2BA2A1Py in the R- and k—spaces.
Labeling efficiency (%) of complexes at different ligand concentrations.
| c(H2BA2A1Py), μM | PbL, %, 0.15 M Ac (No Ac) | CuL, %, 0.15 M Ac |
|---|---|---|
| 1000 | 100 ± 7 | 97 ± 9 |
| 500 | 100 ± 9 | 92 ± 8 |
| 200 | 99 ± 9 | – |
| 100 | 100 ± 8 (99%) | 99 ± 2 |
| 80 | 99 ± 7 | – |
| 50 | 95 ± 9 (99%) | 96 ± 3 |
| 20 | 73 ± 7 | – |
| 10 | 62 ± 3 | 34 ± 2 |
Figure 7Stability of Cu2+ (a) and Pb2+ (b) complexes with BA2A1Py2− compared to complexes with BA3A3− in the presence of serum proteins. Data on M-BA3A complexes are taken from earlier published papers [7,8].